From the journal:

Chemical Communications

Correction: Pre-targeted delivery of a tetrazinylated albumin–zinc(ii) porphyrin complex for tumor photodynamic therapy

Zheng Huang,a   Yinxing Miao, ORCID logo a   Xiaolei Zhao ORCID logo *ab  and  Deju Ye ORCID logo *a  

* Corresponding authors

a State Key Laboratory of Analytical Chemistry for Life Sciences, Chemistry and Biomedicine Innovation Center (ChemBIC), School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, China

b School of Chemical Engineering and Materials, Changzhou Institute of Technology, Changzhou, China

Abstract

Correction for ‘Pre-targeted delivery of a tetrazinylated albumin–zinc(II) porphyrin complex for tumor photodynamic therapy’ by Zheng Huang et al., Chem. Commun., 2026, 62, 1201–1205, https://doi.org/10.1039/D5CC05967D.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/D6CC90194H
Article type
Correction
Submitted
01 Jun 2026
Accepted
01 Jun 2026
First published
16 Jun 2026
This article is Open Access
Creative Commons BY license

Chem. Commun., 2026, Advance Article

Permissions

Request permissions

Correction: Pre-targeted delivery of a tetrazinylated albumin–zinc(II) porphyrin complex for tumor photodynamic therapy

Z. Huang, Y. Miao, X. Zhao and D. Ye, Chem. Commun., 2026, Advance Article , DOI: 10.1039/D6CC90194H

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements